The new expansion covers all patients 6 and older, regardless of their inhibitor status. The new nod also opens up the ...

Fredna Vet Diagnostics successfully performed a CT scan on an Indian Spectacled Cobra, revealing critical trauma details for ...

China Medical System Holdings Limited ("CMS" or the "Group") is pleased to announce that the preclinical results of its self-developed innovative INHBE-targeting small nucleic acid drug CMS-D008 ...

Potentially best-in-mechanism immunogenicity profile, with only 3.7% of participants developing antidrug antibodies Complete blockade of TL1A binding to DR3 for over 3 months expected at doses of 1 mg ...

An international research team has succeeded in elucidating key immunological and biochemical mechanisms underlying ...

Patients with T-cell acute lymphoblastic leukaemia (T-ALL) and the closely related peripheral T-cell lymphoblastic lymphoma ...

Vyvgart first gained approval by the FDA for generalised myasthenia gravis (gMG) in 2021.

Prescription Drug User Fee Act (PDUFA) date of July 7, 2026 for Biologics License Application (BLA) for accelerated approval ...

Potentially best-in-mechanism immunogenicity profile, with only 3.7% of participants developing antidrug antibodies Complete blockade of TL1A binding to DR3 for over 3 months expected at doses of 1 mg ...

So AbCellera is a company based in Vancouver, Canada, also with offices in Montreal, Canada and in Sydney, Australia. Founded in 2012 out of our Founder and CEO, Carl Hansen's lab from the University ...

Obesity has been associated with multiple gastrointestinal cancers, but patients with these malignancies and obesity who have ...

A new clinical trial has shown promising results for cancer patients who no longer benefit from the most common treatment ...